#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4260538	B	Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysis	Homo sapiens	39	ALA4257571	single protein format	Scientific Literature
2.	ALA4260540	B	Inhibition of mouse GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysis	Mus musculus	1	ALA4257571	single protein format	Scientific Literature
3.	ALA4260541	B	Inhibition of rat GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysis	Rattus norvegicus	1	ALA4257571	single protein format	Scientific Literature
4.	ALA4260542	A	Metabolic stability of human liver microsomes assessed as parent compound remaining at 0.1 uM after 60 mins in presence of NADPH by LC/MS/MS analysis	Homo sapiens	13	ALA4257571	microsome format	Scientific Literature
5.	ALA4260543	A	Metabolic stability of rat liver microsomes assessed as parent compound remaining at 0.1 uM after 60 mins in presence of NADPH by LC/MS/MS analysis	Rattus norvegicus	13	ALA4257571	microsome format	Scientific Literature
6.	ALA4260544	A	Metabolic stability of mouse liver microsomes assessed as parent compound remaining at 0.1 uM after 60 mins in presence of NADPH by LC/MS/MS analysis	Mus musculus	13	ALA4257571	microsome format	Scientific Literature
7.	ALA4260545	A	Inhibition of CYP1A2 in human liver microsomes at 10 uM after 20 mins in presence of NADPH by LC/MS/MS analysis relative to control	Homo sapiens	13	ALA4257571	microsome format	Scientific Literature
8.	ALA4260546	A	Inhibition of CYP2D6 in human liver microsomes at 10 uM after 20 mins in presence of NADPH by LC/MS/MS analysis relative to control	Homo sapiens	13	ALA4257571	microsome format	Scientific Literature
9.	ALA4260547	A	Inhibition of CYP3A4 in human liver microsomes at 10 uM after 20 mins in presence of NADPH by LC/MS/MS analysis relative to control	Homo sapiens	13	ALA4257571	microsome format	Scientific Literature
10.	ALA4260548	A	Inhibition of CYP2C9 in human liver microsomes at 10 uM after 20 mins in presence of NADPH by LC/MS/MS analysis relative to control	Homo sapiens	13	ALA4257571	microsome format	Scientific Literature
11.	ALA4260549	A	Inhibition of CYP2C19 in human liver microsomes at 10 uM after 40 mins in presence of NADPH by LC/MS/MS analysis relative to control	Homo sapiens	13	ALA4257571	microsome format	Scientific Literature
12.	ALA4260550	A	Clearance in C57/BL6 mouse at 3 mg/kg, iv	Mus musculus	2	ALA4257571	organism-based format	Scientific Literature
13.	ALA4260551	A	Volume of distribution in C57/BL6 mouse at 3 mg/kg, iv	Mus musculus	2	ALA4257571	organism-based format	Scientific Literature
14.	ALA4260552	A	Half life in C57/BL6 mouse at 3 mg/kg, iv	Mus musculus	2	ALA4257571	organism-based format	Scientific Literature
15.	ALA4260553	A	Cmax in C57/BL6 mouse at 30 mg/kg, po	Mus musculus	2	ALA4257571	organism-based format	Scientific Literature
16.	ALA4260554	A	AUC (0 to 24 hrs) in C57/BL6 mouse at 30 mg/kg, po	Mus musculus	2	ALA4257571	organism-based format	Scientific Literature
17.	ALA4260555	A	Tmax in C57/BL6 mouse at 30 mg/kg, po	Mus musculus	2	ALA4257571	organism-based format	Scientific Literature
18.	ALA4260556	A	Half life in C57/BL6 mouse at 30 mg/kg, po	Mus musculus	2	ALA4257571	organism-based format	Scientific Literature
19.	ALA4260557	A	Oral bioavailability in C57/BL6 mouse at 30 mg/kg	Mus musculus	2	ALA4257571	organism-based format	Scientific Literature
20.	ALA4260558	A	Ratio of drug uptake in lung to plasma of C57/BL6 mouse at 3 mg/kg, iv or 30 mg/kg, po	Mus musculus	2	ALA4257571	organism-based format	Scientific Literature